@article{article, title  = {{Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment}},

 publisher = {{BMJ Publishing Group}},

 url = {{}},

 year = {{2023}},

 month = {{2}},

 author = {{Kamenicky P and Briot K and Brandi ML and Cohen-Solal M and Crowley RK and Keen R and Kolta S and Lachmann RH and Lecoq A-L and Ralston SH and Walsh JS et al}},

 doi = {{10.1136/rmdopen-2022-002676}},

 volume = {{9}},

 journal = {{RMD Open}},

 issue = {{1}},

 note = {{Accessed on 2024/12/29}}}